Schedule 13G ownership disclosure
Ironwood Pharmaceuticals Inc
COMMON STOCK · CUSIP: 46333X108
Event date: 2024-12-31
- Filing-level shares
- 8,328,817.00
- Percent of class
- 5.2%
- STATE STREET CORPORATION
Shares: 8,328,817.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000093751-25-000071
- Form type
- SCHEDULE 13G
- Filer
- IRONWOOD PHARMACEUTICALS INC
- CIK
- CIK 1446847
- Filed
- Feb 05, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership